Early response and safety of lenvatinib for patients with advanced hepatocellular carcinoma in a real‐world setting
Takuya Sho(Hokkaido University), Naoya Sakamoto(Chibaken Saiseikai Narashino Hospital), Masatsugu Ohara(Hokkaido University), Masaru Baba(Hokkaido hospital), Mitsuteru Natsuizaka(Sapporo University), Masato Nakai(Hokkaido University), Megumi Kimura(J. F. Oberlin University), Taku Shigesawa(Hokkaido University), Hideki Yokoo(Hokkaido University), Koji Ogawa(The Japanese Society of Gastroenterological Surgery), Kenichi Morikawa(Hokkaido University), Toshiya Kamiyama(Hokkaido University), Akinobu Taketomi(Hokkaido University), Ken Furuya(Hokkaido hospital), Osamu Maehara(Hokkaido University), Machiko Umemura(Hokkaido University), Yoshiya Yamamoto, Akihisa Nakamura(Hokkaido University), Kazuharu Suzuki(Hokkaido University), Tomoe Kobayashi(Shigei Medical Research Institute), Takuto Miyagishima(Kushiro Rosai Hospital), Takashi Meguro(Hokkaido hospital), Naoki Kawagishi(Hokkaido University), Tomoe Shimazaki(Hokkaido University), Goki Suda(Sapporo University)
Cited by 45
Related Papers
Evidence-based clinical practice guidelines for Liver Cirrhosis 2020
|Journal of Gastroenterology|2021|424
Meflin-Positive Cancer-Associated Fibroblasts Inhibit Pancreatic Carcinogenesis
|Cancer Research|2019|328
Interleukin‐6/<scp>STAT</scp>3 signaling as a promising target to improve the efficacy of cancer immunotherapy
|Cancer Science|2017|295
Genome-wide Association Study Identifies TNFSF15 and POU2AF1 as Susceptibility Loci for Primary Biliary Cirrhosis in the Japanese Population
|The American Journal of Human Genetics|2012|272
Long‐term and perioperative outcomes of laparoscopic versus open liver resection for hepatocellular carcinoma with propensity score matching: a multi‐institutional Japanese study
|Journal of Hepato-Biliary-Pancreatic Sciences|2015|267